Merck to acquire oncology-focused small-molecule firm ArQule
Monday, December 9, 2019 - 16:50
in Health & Medicine
Deal brings noncovalent BTK inhibitor in mid-stage clinical studies
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via